Hepatitis A virus infections in travelers, 1988-2004

Clinical Infectious Diseases

Volumn 42, Issue 4, 2006, Pages 490-497

  Mutsch, Margot ^a,c   Spicher, Virginie Masserey ^b   Gut, Christoph ^a   Steffen, Robert ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HIGH RISK POPULATION; HUMAN; IMMIGRANT; IMPORT DISEASE; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEXICO; PRIORITY JOURNAL; SWITZERLAND; TRAVEL; VACCINATION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; FEMALE; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RISK; STATISTICS, NONPARAMETRIC; SWITZERLAND; TRAVEL;

EID: 32044461589     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/499816     Document Type: Article

References (39)

1. Steffen R, Kane MA, Shapiro CN, et al. Epidemiology and prevention of hepatitis A in travelers. JAMA 1994; 272:885-9.
2. Mutsch M, Tavernini M, Marx A, et al. Influenza virus infection in travelers to tropical and subtropical countries. Clin Infect Dis 2005; 40:1282-7.
3. Teitelbaum P. An estimate of the incidence of hepatitis A in unimmunized Canadian travelers to developing countries. J Travel Med 2004; 11:102-6.
4. Steffen R. Risk of hepatitis A in travellers. Vaccine 1992; 10(Suppl 1):S69-72.
5. Steffen R, Regli P, Grob PJ. Wie gross ist das Risiko einer Reisehepatitis? Schweiz Med Wochenschr 1977; 107:1300-7.
6. Travelers statistics 1988 to 2002. Berne, Switzerland: Swiss Federal Office of Statistics, 2003.
7. United Nations Population Division. World population prospects: the 2002 revision database. Available at: http://esa.un.org/unpp/definition.html. Accessed 8 February 2005.
8. Van Herck K, Castelli F, Zuckerman J, et al. Knowledge, attitudes, and practices regarding travel-related infectious diseases: methodology and results from an airport survey in Europe. J Travel Med 2004; 11:1-7.
9. Gisler S, Steffen R, Mutsch M. Knowledge, attitudes, and practices among travellers to tropical and subtropical countries. Praxis 2005; 94:967-74.
10. Cuzick J. A Wilcoxon-type test for trend. Stat Med 1985; 4:87-90.
11. Behrens R, Carroll B. A decade of travel-associated hepatitis A, typhoid and malaria, vaccine and travel trends in England and Wales. In: Program and abstracts of the 8th International Conference of Travel Medicine (New York). Stone Mountain, GA: International Society of Travel Medicine, 2003:121.
12. De Serres G, Duval B, Shadmani R, et al. Ineffectiveness of the current strategy to prevent hepatitis A in travelers. J Travel Med 2002; 9:10-6.
13. Nothdurft HD, Dahlgren A, Gallagher EA, et al. Consensus recommendations on hepatitis A and hepatitis B vaccination for travel destinations in Central and Eastern Europe and the Mediterranean region. In: Program and abstracts of the 9th International Conference of Travel Medicine (Lisbon). Stone Mountain, GA: International Society of Travel Medicine, 2005:105.
14. Ciccozzi M, Tosti ME, Gallo G, et al. Risk of hepatitis A infection following travel. J Viral Hepat 2002; 9:460-5.
15. Health information for international travel 2005-2006. Atlanta: Centers for Disease Control and Prevention, 2005.
16. Frank C, Walter J, Muehlen M, et al. Large outbreak of hepatitis A in tourists staying at a hotel in Hurghada, Egypt, 2004-orangejuice implicated. Eurosurveill Wkly 2005; 10:2-4.
17. Crowcroft NS. Guidelines for the control of hepatitis A virus infection. Commun Dis Public Health 2001; 4:213-27.
18. Duval B, Boucher F, Dion R, et al. Contrôle de l'hepatite A par l'immunisation au Quebec: rapport final du groupe de travail. Quebec: Ministère de la santé et des service sociaux du Quebec, 1997.
19. Diel R, Schneider S. Transmission of hepatitis A in Hamburg, Germany, 1998-1999-A prospective population based study. Eur J Epidemiol 2001; 17:175-82.
20. Thierfelder W, Meisel H, Schreier E, Dortschy R. Prevalence of antibodies against hepatitis A, B and C viruses among the German population. Gesundheitswesen 1999;61(suppl 2):S110-4.
21. Bell BP, Shapiro CN, Alter MJ, et al. The diverse patterns of hepatitis A epidemiology in the United States-implications for vaccination strategies. J Infect Dis 1998; 178:1579-84.
22. Bacaner N, Stauffer B, Boulware DR, Walker PF, Keystone JS. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA 2004; 291:2856-64.
23. Angell SY, Cetron MS. Health disparities among travelers visiting friends and relatives abroad. Ann Intern Med 2005; 142:67-72.
24. Fulford M, Keystone JS. Health risks associated with visiting friends and relatives in developing countries. Curr Infect Dis Rep 2005; 7: 48-53.
25. Studer S, Joller-Jemelka HI, Steffen R. Prevalence of hepatitis A antibodies in Swiss travellers. Eur J Epidemiol 1993; 9:50-4.
26. Van der Eerden LJ, Bosman A, Van Duynhoven YT. Surveillance of hepatitis A in the Netherlands 1993-2002. Ned Tijdschr Geneeskd 2004; 148:1390-4.
27. Conzelmann-Auer C, Ackermann-Liebrich U, Herzog C, Bachlin A. Hepatitis A outbreak in a kindergarten. Schweiz Med Wochenschr 1992; 122:1559-66.
28. Franco E, Giambi C, lalacci R, Coppola RC, Zanetti AR. Risk groups for hepatitis A virus infection. Vaccine 2003; 21:2224-33.
29. Nainan OV, Armstrong GL, Han XH, et al. Hepatitis A molecular epidemiology in the United States, 1996-1997: sources of infection and implications of vaccination policy. J Infect Dis 2005; 191:957-63.
30. Swiss Federal Office of Public Health. Outbreak of hepatitis at the Canton of Solothurn [in German]. Bulletin Bundesamt für Gesundheit 2002; 7:112-5.
31. Fiore AE. Hepatitis A transmitted by food. Clin Infect Dis 2004;38: 705-15.
32. Craig AS, Schaffner W. Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med 2004; 350:476-81.
33. Van Herck K, Van Damme P. Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence. J Med Virol 2001;63:1-7.
34. Jacobson KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 2004; 132:1005-22.
35. Poovorawan Y, Chatchatee P, Chongsrisawat V. Epidemiology and prophylaxis of hepatitis: a global perspective. J Gastroenterol Hepatol 2002; 17(Suppl):S155-66.
36. Scheifele DW. Hepatitis A vaccines: the growing case for universal immunisation of children. Expert Opin Pharmacother 2005; 6: 157-64.
37. Richardus JH, Vos D, Veldhuijzen IK, Groen J. Seroprevalence of hepatitis A virus antibodies in Turkish and Moroccan children in Rotterdam. J Med Virol 2004; 72:197-202.
38. Samandari T, Bell BP, Armstrong GL. Quantifying the impact of hepatitis A immunization in the United States, 1995-2001. Vaccine 2004; 22:4342-50.
39. Postma MJ, Bos JM, Beutels P, Schilthuis H, van den Hoek JAR. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands). Vaccine 2004; 22:1862-7.